MedPath

Brain Metastasis Development Mechanism in BCBM Patients

Not Applicable
Recruiting
Conditions
Breast Cancer
Brain Metastasis
Interventions
Procedure: WGS/TME evaluation
Registration Number
NCT06330870
Lead Sponsor
Samsung Medical Center
Brief Summary

This study is the experimental study for brain metastasis development mechanism in patients with breast cancer with brain metastasis

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Breast cancer
  • Brain metastasis curative surgery patient
Exclusion Criteria
  • Gamma Knife surgery patient

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
WGS/TME evaluationWGS/TME evaluationThis is not intervention clinical trial design. We explore whole genome sequencing and tumor microenvironment evaluation for brain metastasis specimen in breast cancer patients.
Primary Outcome Measures
NameTimeMethod
Intracranial disease free survivalMonths

Time to new brain metastasis or brain metastasis progression from the brain surgery

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ji-Yeon Kim

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath